All Relations between Depression and cannabis

Publication Sentence Publish Date Extraction Date Species
Jillian E Halladay, Catharine Munn, Michael Boyle, Susan M Jack, Katholiki Georgiade. Temporal Changes in the Cross-Sectional Associations between Cannabis Use, Suicidal Ideation, and Depression in a Nationally Representative Sample of Canadian Adults in 2012 Compared to 2002. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 65. issue 2. 2021-05-26. PMID:31177831. temporal changes in the cross-sectional associations between cannabis use, suicidal ideation, and depression in a nationally representative sample of canadian adults in 2012 compared to 2002. 2021-05-26 2023-08-13 Not clear
Paul C Langle. Establishing Credibility for Medical Marijuana: The Proposed Prometheus Dispensary Registry for Botanical Cannabis. Innovations in pharmacy. vol 10. issue 1. 2021-05-20. PMID:34007525. the registry tracks and reports on patients over the course of treatment with botanical cannabis with the focus on severe or chronic non-cancer pain, severe nausea, persistent muscle spasms and seizures, together with prevalent comorbidities - fatigue, anxiety, depression and sleep. 2021-05-20 2023-08-13 Not clear
Andrew Salzwedel, Gang Chen, Yuanyuan Chen, Karen Grewen, Wei Ga. Functional dissection of prenatal drug effects on baby brain and behavioral development. Human brain mapping. vol 41. issue 17. 2021-05-17. PMID:32779835. in this study, based on a large sample of 133 human neonates and leveraging a novel linear mixed-effect model designed for intersubject variability analyses, we studied the effects of six prenatally exposed drugs (i.e., nicotine, alcohol, selective serotonin reuptake inhibitor, marijuana, cocaine, and opioids) on neonatal whole-brain functional organization and compared them with five other critical nondrug variables (i.e., gestational age at birth/scan, sex, birth weight, and maternal depression). 2021-05-17 2023-08-13 human
Amanda J Sales, Francisco S Guimarães, Sâmia R L Joc. CBD modulates DNA methylation in the prefrontal cortex and hippocampus of mice exposed to forced swim. Behavioural brain research. vol 388. 2021-05-04. PMID:32348868. cannabidiol (cbd), a non-psychotomimetic component of cannabis sativa plant, shows therapeutic potential in psychiatric disorders, including depression. 2021-05-04 2023-08-13 mouse
Tetiana Kardash, Dmitry Rodin, Michael Kirby, Noa Davis, Igor Koman, Jonathan Gorelick, Izhak Michaelevski, Albert Pinhaso. Link between personality and response to THC exposure. Behavioural brain research. vol 379. 2021-05-03. PMID:31734264. the effects of cannabis reported by users range from experiences of euphoria and anxiolytic effects to paranoia, anxiety, and increased risk of depression. 2021-05-03 2023-08-13 mouse
Clarissa Laczkovics, Oswald D Kothgassner, Anna Felnhofer, Claudia M Klie. Cannabidiol treatment in an adolescent with multiple substance abuse, social anxiety and depression. Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater. vol 35. issue 1. 2021-04-27. PMID:32052321. cannabidiol treatment in an adolescent with multiple substance abuse, social anxiety and depression. 2021-04-27 2023-08-13 Not clear
Vivian N Onaemo, Timothy O Fawehinmi, Carl D'Arc. Comorbid Cannabis Use Disorder with Major Depression and Generalized Anxiety Disorder: A Systematic Review with Meta-analysis of Nationally Representative Epidemiological Surveys. Journal of affective disorders. vol 281. 2021-04-21. PMID:33360749. comorbid cannabis use disorder with major depression and generalized anxiety disorder: a systematic review with meta-analysis of nationally representative epidemiological surveys. 2021-04-21 2023-08-13 Not clear
Kenneth Blum, Jag Khalsa, Jean Lud Cadet, David Baron, Abdalla Bowirrat, Brent Boyett, Lisa Lott, Raymond Brewer, Marjorie Gondré-Lewis, Gregory Bunt, Shan Kazmi, Mark S Gol. Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans: Embracing Putative Induction of Dopamine Homeostasis. Frontiers in psychiatry. vol 12. 2021-04-21. PMID:33868044. research shows that exposure to cannabis is associated with hypodopaminergic anhedonia (depression), cognitive decline, poor memory, inattention, impaired learning performance, reduced dopamine brain response-associated emotionality, and increased addiction severity in young adults. 2021-04-21 2023-08-13 Not clear
Kenneth Blum, Jag Khalsa, Jean Lud Cadet, David Baron, Abdalla Bowirrat, Brent Boyett, Lisa Lott, Raymond Brewer, Marjorie Gondré-Lewis, Gregory Bunt, Shan Kazmi, Mark S Gol. Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans: Embracing Putative Induction of Dopamine Homeostasis. Frontiers in psychiatry. vol 12. 2021-04-21. PMID:33868044. preliminary research suggests that it is possible to induce 'dopamine homeostasis,' that is, restore dopamine function with dopamine upregulation with the proposed compound and normalize behavior in chronic cannabis users with cannabis-induced hypodopaminergic anhedonia (depression) and cognitive decline. 2021-04-21 2023-08-13 Not clear
Denise C Vidot, Sapna Deo, Sylvia Daunert, Willie L Joseph, Nestor de la Cruz-Munoz, Sarah E Messia. A Preliminary Study on the Influence of Cannabis and Opioid Use on Weight Loss and Mental Health Biomarkers Post-weight Loss Surgery. Obesity surgery. vol 30. issue 11. 2021-04-14. PMID:32860570. a subpopulation of weight loss surgery (wls) patients endorse cannabis and/or opioid use; however, impact on post-wls anxiety and depression is unclear. 2021-04-14 2023-08-13 Not clear
Denise C Vidot, Sapna Deo, Sylvia Daunert, Willie L Joseph, Nestor de la Cruz-Munoz, Sarah E Messia. A Preliminary Study on the Influence of Cannabis and Opioid Use on Weight Loss and Mental Health Biomarkers Post-weight Loss Surgery. Obesity surgery. vol 30. issue 11. 2021-04-14. PMID:32860570. this study examined the influence of the independent and combined use of cannabis and opioids on (1) depression and anxiety, (2) duodenum serotonin and cortisol, and (3) total percent weight loss. 2021-04-14 2023-08-13 Not clear
Philip A Spechler, Jennifer L Stewart, Rayus Kuplicki, Martin P Paulu. Parsing impulsivity in individuals with anxiety and depression who use Cannabis. Drug and alcohol dependence. vol 217. 2021-04-12. PMID:33002704. parsing impulsivity in individuals with anxiety and depression who use cannabis. 2021-04-12 2023-08-13 Not clear
Rynaz Rabiee, Andreas Lundin, Emilie Agardh, Gunnel Hensing, Peter Allebeck, Anna-Karin Danielsso. Cannabis use and the risk of anxiety and depression in women: A comparison of three Swedish cohorts. Drug and alcohol dependence. vol 216. 2021-04-05. PMID:33080503. cannabis use and the risk of anxiety and depression in women: a comparison of three swedish cohorts. 2021-04-05 2023-08-13 Not clear
Rynaz Rabiee, Andreas Lundin, Emilie Agardh, Gunnel Hensing, Peter Allebeck, Anna-Karin Danielsso. Cannabis use and the risk of anxiety and depression in women: A comparison of three Swedish cohorts. Drug and alcohol dependence. vol 216. 2021-04-05. PMID:33080503. the associations between cannabis use and anxiety or depression remain unclear. 2021-04-05 2023-08-13 Not clear
Zsolt Gáll, Szidónia Farkas, Ákos Albert, Elek Ferencz, Szende Vancea, Melinda Urkon, Melinda Kolcsá. Effects of Chronic Cannabidiol Treatment in the Rat Chronic Unpredictable Mild Stress Model of Depression. Biomolecules. vol 10. issue 5. 2021-04-02. PMID:32455953. effects of chronic cannabidiol treatment in the rat chronic unpredictable mild stress model of depression. 2021-04-02 2023-08-13 rat
Marta Torrens, Judit Tirado-Muñoz, Francina Fonseca, Magi Farré, Ana Gonzalez-Pinto, Manuel Arrojo, Miquel Bernardo, Belen Arranz, Marina Garriga, Pilar A Saiz, Gerardo Florez, Jose Manuel Goikolea, Iñaki Zorrilla, Ruth Cunill, Xavier Castells, Elisardo Becoña, Ana Lopez, Luis Sa. Clinical practice guideline on pharmacological and psychological management of adult patients with depression and a comorbid substance use disorder. Adicciones. vol 0. issue 0. 2021-03-26. PMID:33768269. 2) in patients with depression and cannabis use, the use of venlafaxine is not recommended (weak recommendation). 2021-03-26 2023-08-13 Not clear
Daniel Feingold, Silviu Brill, Itay Goor-Aryeh, Yael Delayahu, Shaul Lev-Ra. Depression level, not pain severity, is associated with smoked medical marijuana dosage among chronic pain patients. Journal of psychosomatic research. vol 135. 2021-03-22. PMID:32417435. depression level, not pain severity, is associated with smoked medical marijuana dosage among chronic pain patients. 2021-03-22 2023-08-13 Not clear
Lauren R Pacek, Andrea H Weinberger, Jiaqi Zhu, Renee D Goodwi. Rapid increase in the prevalence of cannabis use among people with depression in the United States, 2005-17: the role of differentially changing risk perceptions. Addiction (Abingdon, England). vol 115. issue 5. 2021-03-08. PMID:31797462. rapid increase in the prevalence of cannabis use among people with depression in the united states, 2005-17: the role of differentially changing risk perceptions. 2021-03-08 2023-08-13 Not clear
Lauren R Pacek, Andrea H Weinberger, Jiaqi Zhu, Renee D Goodwi. Rapid increase in the prevalence of cannabis use among people with depression in the United States, 2005-17: the role of differentially changing risk perceptions. Addiction (Abingdon, England). vol 115. issue 5. 2021-03-08. PMID:31797462. to estimate trends in the prevalence of cannabis use and risk perceptions of cannabis use from 2005 to 2017 among united states people with and without depression. 2021-03-08 2023-08-13 Not clear
Renee D Goodwin, Jiaqi Zhu, Zoe Heisler, Torri D Metz, Katarzyna Wyka, Melody Wu, Rina Das Eide. Cannabis use during pregnancy in the United States: The role of depression. Drug and alcohol dependence. vol 210. 2021-03-02. PMID:32143978. cannabis use during pregnancy in the united states: the role of depression. 2021-03-02 2023-08-13 Not clear